Methods:The study included23normal control(controls group)and34patients with chronic kidney disease(CKD group)who received intervenous drop in-fusion treatment with thymic peptide50mg plus normal sodium100ml every day,four weeks in all.

• 方法正常对照组23例,CKD组为肾功能正常的患者34例,用胸腺肽50mg,加入生理盐水100ml中,静脉滴注,每天1次,连续4周。